Comparative Effectiveness of Once-Weekly Semaglutide Versus Sulfonylureas, DPP4 Inhibitors, and Thiazolidinediones in Patients with Type 2 Diabetes and Chronic Kidney Disease
- DOI
- 10.1007/s12325-026-03744-8
- Published
- 2026-09-23
- Container
- Advances in Therapy
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-026-03744-8,
title = {Comparative Effectiveness of Once-Weekly Semaglutide Versus Sulfonylureas, DPP4 Inhibitors, and Thiazolidinediones in Patients with Type 2 Diabetes and Chronic Kidney Disease},
author = {James Amamoo and Yan Wang and Hongjiao Liu and Manasvi Sundar and Yan Song and Lin Xie and Sherif Mehanna and Josh Noone and Caroline Swift and Matthew R. Weir},
year = {2026},
journal = {Advances in Therapy},
doi = {10.1007/s12325-026-03744-8},
url = {https://doi.org/10.1007/s12325-026-03744-8}
}RIS
TY - JOUR TI - Comparative Effectiveness of Once-Weekly Semaglutide Versus Sulfonylureas, DPP4 Inhibitors, and Thiazolidinediones in Patients with Type 2 Diabetes and Chronic Kidney Disease AU - James Amamoo AU - Yan Wang AU - Hongjiao Liu AU - Manasvi Sundar AU - Yan Song AU - Lin Xie AU - Sherif Mehanna AU - Josh Noone AU - Caroline Swift AU - Matthew R. Weir PY - 2026 JO - Advances in Therapy DO - 10.1007/s12325-026-03744-8 UR - https://doi.org/10.1007/s12325-026-03744-8 ER -
APA
Amamoo, J., Wang, Y., Liu, H., Sundar, M., Song, Y., Xie, L., Mehanna, S., Noone, J., Swift, C., & Weir, M. R. (2026). Comparative Effectiveness of Once-Weekly Semaglutide Versus Sulfonylureas, DPP4 Inhibitors, and Thiazolidinediones in Patients with Type 2 Diabetes and Chronic Kidney Disease. Advances in Therapy. https://doi.org/10.1007/s12325-026-03744-8
Source records
- crossref · retrieved 2026-09-25T21:41:58.731Z